{"slideshow_credits": null, "snippet": "Valeant Pharmaceuticals, which has been criticized for sharp increases in drug prices, said it had received two federal subpoenas.", "abstract": "Valeant Pharmaceuticals International says it has received two federal subpoenas connected to its pricing, distribution and patient support practices;  has been criticized for greatly raising prices of its drugs.", "section_name": "Business Day", "print_page": "5", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/10/15/business/valeant-under-investigation-for-its-drug-pricing-practices.html", "lead_paragraph": "Valeant Pharmaceuticals, which has been criticized for sharp increases in drug prices, said it had received two federal subpoenas.", "headline": {"main": "Valeant Under Investigation for Its Drug Pricing Practices", "print_headline": "Valeant Under Investigation for Its Drug Pricing Practices"}, "_id": "561f20c738f0d81699b2b9df", "word_count": "537", "multimedia": [{"height": 126, "url": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 391, "url": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-articleLarge.jpg", "legacy": {"xlarge": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "391"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-10-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}